Nembutal Lethal Dose Clinical ethics and harm reduction in drug safety

Nembutal Lethal Dose

Clinical ethics and harm reduction in drug safety

Latest Articles

The Counting Problem Beneath Barbiturate Risk: Why Death Certificate Data Need a Surveillance Upgrade
Clinical Ethics

The Counting Problem Beneath Barbiturate Risk: Why Death Certificate Data Need a Surveillance Upgrade

Death certificates are legal documents, not epidemiologic instruments, and barbiturate mortality data inherit that limitation. Better toxicology reporting and coding could make hidden risk visible without turning grief into paperwork.

Intent Before Vocabulary: A Palliative Care Framework for 'Lethal Dose' Policy
Clinical Ethics

Intent Before Vocabulary: A Palliative Care Framework for 'Lethal Dose' Policy

Palliative sedation, terminal extubation, and deliberate lethal dosing are not the same act, yet policy and media often fold them into one phrase. This ethics analysis argues that clearer terminology is a safeguard for patients, clinicians, and regulators.

The Cabinet as a Public-Health Question: Auditing Leftover Barbiturates in U.S. Homes
Drug Safety & Policy

The Cabinet as a Public-Health Question: Auditing Leftover Barbiturates in U.S. Homes

Lethal-dose debates usually begin with the person seeking a number, but the household is where risk often accumulates. This 2026 audit examines how leftover barbiturates move through American homes and what clinicians and public-health agencies can do without alarmism.

The Label Is Not a Risk Calculator: Reading FDA Inserts and Poison Center Guidance on Barbiturates
Clinical Ethics

The Label Is Not a Risk Calculator: Reading FDA Inserts and Poison Center Guidance on Barbiturates

Package inserts and poison center protocols are often treated as neutral sources of clarity, but they are built for regulatory review and triage, not individualized lethality counseling. For barbiturates, that distinction matters more than clinicians may realize.

The Rescue Drug That Isn't There: What Naloxone's Success Reveals About Barbiturate Overdose Planning
Drug Safety & Policy

The Rescue Drug That Isn't There: What Naloxone's Success Reveals About Barbiturate Overdose Planning

Naloxone gave US harm reduction a clear rescue product, a trained bystander role, and a policy template. Barbiturate poisoning has no equivalent reversal agent, which means clinicians and policymakers need a different rescue conversation rather than a borrowed slogan.

Answering Without Instructing: An Ethical Framework for Clinicians Facing Public Lethal-Dose Questions
Clinical Ethics

Answering Without Instructing: An Ethical Framework for Clinicians Facing Public Lethal-Dose Questions

Members of the public increasingly ask lethal-dose questions in forums, comment sections, and search-driven encounters, and clinicians are being drawn into answering them. This policy piece maps the competing duties at stake and proposes a triage framework and institutional guidance for US health systems and professional bodies in 2026.

One Number, Many Variables: How Single Lethal-Dose Figures Mislead American Clinicians and Regulators
Drug Safety & Policy

One Number, Many Variables: How Single Lethal-Dose Figures Mislead American Clinicians and Regulators

A lone lethal-dose figure migrates from laboratory report to headline to hearing with its qualifications stripped away. This analysis unpacks the species, route, formulation, and population variables that a single number conceals, and offers a practical checklist for evaluating lethal-dose claims in media, online content, and regulatory debate.